Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31052134 | 0.83 | ADRB1 (0.55) | HTR1ADRD2 | |
| SCHEMBL31051899 | 0.77 | HTR1A (0.43) | HTR1ADRD2 | |
| SCHEMBL31051934 | 0.77 | HTR1A (0.43) | HTR1ADRD2 | |
| SCHEMBL31052023 | 0.77 | ADRB1 (0.61) | HTR1A | |
| SCHEMBL31052031 | 0.73 | ADRB1 (0.36) | — | |
| SCHEMBL31052136 | 0.72 | DRD2 (0.51) | HTR1ADRD2 | |
| SCHEMBL31051735 | 0.72 | ADRB1 (0.52) | HTR1ADRD2 | |
| SCHEMBL31051940 | 0.71 | DRD2 (0.48) | HTR1ADRD2 | |
| SCHEMBL31052163 | 0.70 | NPC1 (0.43) | HTR1ADRD2 | |
| SCHEMBL7818467 | 0.69 | HTR1A (0.47) | HTR1ADRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678188-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING, OR MANAGING BILIRUBIN-INDUCED NEUROLOGICAL DYSFUNCTION, PSYCHIATRIC DISORDERS ASSOCIATED WITH JAUNDICE, OR PSYCHIATRIC DISORDERS CAUSED BY BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE GENE MUTATIONS | Ohnishi, Arata (JP) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024185842-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING, OR MANAGING BILIRUBIN-INDUCED NEUROLOGICAL DYSFUNCTION, PSYCHIATRIC DISORDERS ASSOCIATED WITH JAUNDICE, OR PSYCHIATRIC DISORDERS CAUSED BY BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE GENE MUTATIONS | 国立大学法人島根大学 | 2024-09-12 | — | — | WO | disclosed |